Transaction DateRecipientSharesTypePriceValue
13th August 2020Bradley S Hargreaves1,234,855Exercise of derivative$0.05$61,742.75
13th August 2020Jean M Arnett1,250,000Exercise of derivative$0.05$62,500.00
30th July 2020Frank Mcenulty40,000Open or private purchase$0.25$10,000.00
28th April 2020Richard Jeffs1,665Open or private sale$0.60$999.00
27th April 2020Richard Jeffs15,607Open or private sale$0.60$9,364.20
24th April 2020Richard Jeffs5,500Open or private purchase$0.42$2,332.00
21st April 2020Richard Jeffs1,000,000Open or private purchase$0.15$150,000.00
16th April 2020Richard Jeffs5,000Open or private purchase$0.32$1,600.00
15th April 2020Richard Jeffs5,000Open or private purchase$0.33$1,650.00
15th April 2020Richard Jeffs5,000Open or private purchase$0.33$1,648.00
Cell Med X
Cell Med X logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.


Cell MedX Corp. was founded on March 19, 2010 and is headquartered in Carson City, NV. Its products include electromedical technology, and ebalance technology for diabetes and related complications.


Ticker: CMXC
Sector: Healthcare
Industry: Diagnostics & Research
SEC Central Index Key (CIK): 1493712
Employees:
Exchange: US OTC
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals